Last Updated on June 22, 2023

Neurodegenerative disease management- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Future Medicine Ltd.

Abbreviation: Neurodegener. dis. manag.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

2.18

SJR

 0.518

h-Index

 29

Rank

 10020

Important Details

Title Neurodegenerative disease management
Standard Abbreviation Neurodegener. dis. manag.
Type of Publication Journal
Discipline Medicine (miscellaneous) (Q2); Neurology (clinical) (Q3)
Impact Score 2.18
SCImago Journal Rank (SJR) 0.518
h-index 29
Overall Rank 10020
Publisher Name Future Medicine Ltd.
Publication Country United Kingdom
International Standard Serial Number (ISSN) 17582024, 17582032
Coverage and History 2014-2022
Best Quartile Q2
Total Citations Received
(Last 3 Year)
218

About Neurodegenerative disease management


Neurodegenerative disease management is a journal published by Future Medicine Ltd.. This journal covers the area[s] related to Medicine (miscellaneous), Neurology (clinical), etc. The coverage history of this journal is as follows: 2014-2022. The rank of this journal is 10020. This journal's impact score, h-index, and SJR are 2.18, 29, and 0.518, respectively. The ISSN of this journal is/are as follows: 17582024, 17582032.

The best quartile of Neurodegenerative disease management is Q2. This journal has received a total of 218 citations during the last three years (Preceding 2022).


Neurodegenerative disease management Impact Score 2022-2023


The latest impact score (IS) of the Neurodegenerative disease management is 2.18. It is computed in the year 2023 as per its definition and based on Scopus data. 2.18

It is decreased by a factor of around 0.05, and the percentage change is -2.24% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Neurodegenerative disease management Impact Score 2023


Impact Score 2022 of Neurodegenerative disease management is 2.18. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Neurodegenerative disease management. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.18
2021 2.23
2020 2.27
2019 1.52
2018 1.51
2017 1.62
2016 1.55
2015 1.45
2014 0.00

Neurodegenerative disease management h-index


  Table Setting

The h-index of Neurodegenerative disease management is 29. By definition of the h-index, this journal has at least 29 published articles with more than 29 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Neurodegenerative disease management ISSN


The International Standard Serial Number (ISSN) of Neurodegenerative disease management is/are as follows: 17582024, 17582032.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Neurodegenerative disease management Ranking and SCImago Journal Rank (SJR)


The Neurodegenerative disease management is ranked 10020 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.518.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Neurodegenerative disease management Publisher


Table Setting

The publisher of Neurodegenerative disease management is Future Medicine Ltd.. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2014-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Neurodegenerative disease management is Neurodegener. dis. manag.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Neurodegener. dis. manag.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Neurodegenerative disease management


If your area of research or discipline is related to Medicine (miscellaneous), Neurology (clinical), etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Neurodegenerative disease management?

The latest impact score of Neurodegenerative disease management is 2.18. It is computed in the year 2023.


What is the h-index of Neurodegenerative disease management?

The latest h-index of Neurodegenerative disease management is 29. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Neurodegenerative disease management?

The latest SCImago Journal Rank (SJR) of Neurodegenerative disease management is 0.518. It is calculated in the year 2023.


What is the ranking of Neurodegenerative disease management?

The latest ranking of Neurodegenerative disease management is 10020. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Neurodegenerative disease management?

Neurodegenerative disease management is published by Future Medicine Ltd.. The publication country of this journal is United Kingdom.


What is the abbreviation of Neurodegenerative disease management?

This standard abbreviation of Neurodegenerative disease management is Neurodegener. dis. manag..


Is "Neurodegenerative disease management" a Journal, Conference or Book Series?

Neurodegenerative disease management is a journal published by Future Medicine Ltd..


What is the scope of Neurodegenerative disease management?

The scope of Neurodegenerative disease management is as follows:

  • Medicine (miscellaneous)
  • Neurology (clinical)

For detailed scope of Neurodegenerative disease management, check the official website of this journal.


What is the ISSN of Neurodegenerative disease management?

The International Standard Serial Number (ISSN) of Neurodegenerative disease management is/are as follows: 17582024, 17582032.


What is the best quartile for Neurodegenerative disease management?

The best quartile for Neurodegenerative disease management is Q2.


What is the coverage history of Neurodegenerative disease management?

The coverage history of Neurodegenerative disease management is as follows 2014-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Discourse Journal Routledge 6621 59 2.11
Palaeontographica Abteilung B: Palaeophytologie Book Series E. Schweizerbart'sche Verlagsbuchhandlung 15138 16 2.20
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS Conference And Proceedings Association for Computing Machinery (ACM) 781 100 8.01
Biological Procedures Online Journal BioMed Central Ltd. 3350 43 6.40
Proceedings of the Royal Society of Queensland Journal Royal Society of Queensland 22998 12 0.48
Revista de Metodos Cuantitativos para la Economia y la Empresa Journal Universidad Pablo de Olavide 22138 10 0.37
International Journal of Data Mining and Bioinformatics Journal Inderscience Enterprises Ltd. 23114 24 0.40
Endangered Species Research Journal Inter-Research 4658 66 3.20
Enterprise Information Systems Journal Taylor and Francis Ltd. 3964 54 5.22
Best Practice and Research in Clinical Anaesthesiology Journal Bailliere Tindall Ltd 4377 77 4.97

Check complete list




Neurodegenerative disease management Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 2.18
2021 2.23
2020 2.27
2019 1.52
2018 1.51
2017 1.62
2016 1.55
2015 1.45
2014 0.00



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Annual Review of Public Health
Annual Reviews Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Stroke
American Heart Association | United States

European Stroke Journal
SAGE Publications Inc. | United States

Annual Review of Vision Science
Annual Reviews Inc. | United States

See All